Cord blood-derived dendritic cell (CBDC)

Cord blood-derived dendritic cells (CBDCs) are specialized antigen-presenting cells (APCs) that originate from hematopoietic stem cells or monocytes found in umbilical cord blood (Zhu et al., 2021, PMID: 33407830). They serve as a critical bridge between innate and adaptive immunity, though they are characterized by a more immature functional state compared to adult peripheral blood dendritic cells. This immaturity is marked by lower baseline expression of co-stimulatory molecules such as CD80 and CD86, which often results in a bias toward immune tolerance or Th2-type responses (Goriely et al., 2001, PMID: 11448846). This unique immunological profile is a primary reason for the lower incidence and severity of graft-versus-host disease (GvHD) observed in umbilical cord blood transplantations (Beksac et al., 2017, PMID: 28848714). In therapeutic contexts, CBDCs are not a single molecular target but a cellular platform used in immunotherapy and vaccine development. They possess a full repertoire of innate receptors, including Toll-like receptors (TLRs), which can be targeted by agonists like Poly I:C or LPS to induce maturation and enhance their ability to prime T cells (De Wit et al., 2003, PMID: 12869513). Researchers explore CBDCs for cancer vaccines by loading them with tumor-associated antigens to stimulate anti-tumor T-cell responses. However, their propensity for inducing tolerance remains a challenge in ensuring robust clinical efficacy. The term provided is considered 'incorrect' as a target because it describes a complex cell population and its associated signaling machinery rather than a specific, individual therapeutic protein or receptor.

Other names

Umbilical cord blood-derived dendritic cellCB-DCCord blood DCNeonatal dendritic cell

Cord blood-derived dendritic cells (CBDCs) function by capturing, processing, and presenting antigens via Major Histocompatibility Complex (MHC) class I and II molecules to T cells. Their co-stimulatory machinery, including CD80, CD86, and CD40, provides the essential secondary signals required for T-cell proliferation and differentiation. Additionally, their innate receptors, such as Toll-like receptors (TLRs), recognize pathogen-associated molecular patterns (PAMPs) to trigger maturation and the secretion of polarizing cytokines like IL-12 or IL-10.